The Spectator

Portrait of the week: Vaccine hopes up, Zoom shares down and Biden calls Boris

issue 14 November 2020

Home

Pfizer and BioNTech announced a vaccine against Covid-19 of 90 per cent efficacy from two injections three weeks apart. It was not known if it prevented transmission of the virus. The vaccine has to be stored at an ultra-low temperature of minus 80˚C. In July, the British government had bought 40 million doses, enough for a third of the population, with ten million available by the end of the year (along with access to five other vaccine candidates, totalling 340 million doses in all). The army and police planned vaccination centres. Shares in air transport went up; shares in Zoom went down. Asked whether we could say with confidence that life should be returning to normal by spring, Sir John Bell, the Regius Professor of Medicine at Oxford, said: ‘Yes, yes, yes.’

At the beginning of the week, Sunday 8 November, total deaths (within 28 days of testing positive for the coronavirus) had stood at 48,888, including 2,333 in the past week, compared with 1,810 the week before.

Comments

Join the debate for just $5 for 3 months

Be part of the conversation with other Spectator readers by getting your first three months for $5.

Already a subscriber? Log in